April 10, 2014
A total of 17 patients have died in Japan after taking Janssen Pharmaceutical K.K.’s schizophrenia agent Xeplion (paliperidone palmitate ester) since it hit the market last November, it has been reported. Although it is still unclear if there is a...read more